0
The FDA has approved a five-day, once-daily IV and oral 750-mg regimen of levofloxacin (Levaquin drug, Ortho-McNeil, PriCara) for patients with complicated urinary tract infections (UTIs) and acute pyelonephritis (kidney infection).
The FDA has approved a five-day, once-daily IV and oral 750-mg regimen of generic levofloxacin (Levaquin drags, Ortho-McNeil, PriCara) for patients with complicated urinary tract infections (UTIs) and acute pyelonephritis (kidney infection).
Studies have shown that formulary restrictions can be an effective means of controlling drug use, but concerns have arisen about clinical consequences, say researchers from Canada. One retrospective study, for example, suggested that restricting fluoroquinolones drug could lead to more hospitalizations for pyelonephritis and bronchitis. To confirm these findings, the researchers conducted a study using a database of 1.4 million older adults.
